Dissolved
CVR: 30723589
Previous names: ENTROP PHARMA A/S
Not available
No owners listed
CVR · view owners
No management registered
CVR · view management
Dissolved
Ceased 31 May 2013
CVR · view overview
No headcount reported
Director role ended: Jakob Mosegaard Larsen
CVR · 31/05/2013
View the full event history
ENTROP PHARMA ApS was a Danish company of the type Anpartsselskab based in København K, founded in 2007. The company has been dissolved on 31 May 2013. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ENTROP PHARMA A/S.
No annual financial figures are available for this company.
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningNo. ENTROP PHARMA ApS is registered in the Danish CVR register with the status Dissolved and ceased on 31 May 2013.
The CVR number of ENTROP PHARMA ApS is 30723589.
ENTROP PHARMA ApS was founded on 11 July 2007.
ENTROP PHARMA ApS was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721900).
ENTROP PHARMA ApS was located at c/o NB Capital ApS, Østergade 24A 1. tv, 1100 København K.
ENTROP PHARMA ApS has published its interim report for the period January 1, 2012 to May 20, 2013.
As of May 31, 2013, JUT NR. 2180 A/S has stepped down as auditor of ENTROP PHARMA ApS.
As of May 31, 2013, Jakob Mosegaard Larsen has stepped down as liquidator of ENTROP PHARMA ApS.
On May 31, 2013, ENTROP PHARMA ApS exited liquidation.
ENTROP PHARMA ApS was dissolved on May 31, 2013.
As of February 13, 2013, Jakob Mosegaard Larsen is registered as liquidator of ENTROP PHARMA ApS.
As of February 13, 2013, Florian Schønharting has stepped down as direktion of ENTROP PHARMA ApS.
On February 13, 2013, ENTROP PHARMA ApS entered liquidation.
As of April 16, 2012, Christian Karsten Hansen has left the board of directors of ENTROP PHARMA ApS.
As of April 16, 2012, Wyle David Solomon has left the board of directors of ENTROP PHARMA ApS.
As of April 16, 2012, Florian Schønharting is registered as direktion of ENTROP PHARMA ApS.
As of April 16, 2012, Christian Karsten Hansen has stepped down as direktion of ENTROP PHARMA ApS.
As of April 16, 2012, Florian Schønharting has stepped down as chairman of ENTROP PHARMA ApS.
On April 16, 2012, the company changed its name from ENTROP PHARMA A/S to ENTROP PHARMA ApS.
As of August 2, 2011, JUT NR. 2180 A/S has been appointed auditor of ENTROP PHARMA ApS.
As of August 2, 2011, EY Danmark A/S has stepped down as auditor of ENTROP PHARMA ApS.
As of November 21, 2008, Wyle David Solomon has joined the board of directors of ENTROP PHARMA ApS.
As of November 21, 2008, Cora Louise Madsen has left the board of directors of ENTROP PHARMA ApS.
As of July 11, 2007, EY Danmark A/S has been appointed auditor of ENTROP PHARMA ApS.
As of July 11, 2007, Christian Karsten Hansen has joined the board of directors of ENTROP PHARMA ApS.
As of July 11, 2007, Cora Louise Madsen has joined the board of directors of ENTROP PHARMA ApS.
As of July 11, 2007, Christian Karsten Hansen is registered as direktion of ENTROP PHARMA ApS.
As of July 11, 2007, Florian Schønharting is registered as chairman of ENTROP PHARMA ApS.
ENTROP PHARMA ApS was founded on July 11, 2007.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed
